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Melanoma Cell Invasiveness Is Promoted at Least in
Part by the Epidermal Growth Factor–Like Repeats
of Tenascin-C
Jelena Grahovac1, Dorothea Becker1 and Alan Wells1,2
Tenascin-C (TNC), overexpressed in invasive growths, has been implicated in progression of melanoma, but the
source and function of this molecule are not well defined. We found TNC expression at the front of invading
melanoma cells, and that adding TNC to matrices enhances individual melanoma cell migration. As TNC is a
multidomain protein, we examined the role of the TNC EGF-like (EGFL) repeats as these activate motogenic
signaling cascades. We overexpressed a TNC fragment containing the assembly and EGFL domains of TNC
(TNCEGFL). TNCEGFL-expressing melanoma cells had lower speed and persistence in 2D migration assays due
to a shift in the adhesion–contractility balance, as expression of TNCEGFL delayed melanoma cell attachment
and spreading. The less adhesive phenotype was due, in part, to increased Rho-associated kinase (ROCK)
signaling concomitant with myosin light chain 2 and MYPT phosphorylation. Inhibition of ROCK activity, which
drives transcellular contractility, restored adhesion of TNCEGFL-expressing melanoma cells and increased their
migration in 2D. In contrast to the diminished migration in 2D, TNCEGFL-expressing melanoma cells had higher
invasive potential in Matrigel invasion assays, with cells expressing TNCEGFL having amoeboid morphology.
Our findings suggest that melanoma-derived TNCEGFL exert a role in melanoma invasion by modulating ROCK
signaling and cell migration.
Journal of Investigative Dermatology (2013) 133, 210–220; doi:10.1038/jid.2012.263; published online 6 September 2012
INTRODUCTION
Melanoma, which continues to increase in frequency, has a
very low response rate to current therapies, with the tumor
invading through a collagen-rich dermis to disseminate to
ectopic sites. The transition from melanoma in situ and radial
growth phase to the vertical growth phase melanoma is
poorly understood. The invasive aspects of tumor progression
represent complex molecular events, which involve recogni-
tion and remodeling of extracellular matrix (ECM), changes in
intracellular signaling, and reorganization of the cytoskele-
ton, allowing for enhanced motility of tumor cells (Wells,
2000; Friedl and Gilmour, 2009). Although there are
numerous changes in both the melanoma cells and the
dermis during this progression, one striking feature is the
reexpression of Tenascin-C (TNC) (Ilmonen et al., 2004;
Kaariainen et al., 2006; Hood et al., 2010). TNC is an ECM
protein linked to development and tissue regeneration along
with tumor invasion (Jones and Jones, 2000; Midwood et al.,
2011). TNC is barely detectable in normal skin, but present in
substantial amounts in advanced melanoma, particularly at the
invasive fronts, and lack of detectable TNC in primary
melanoma lesions has been shown to correlate with a lower
risk of developing metastases (Kaariainen et al., 2006). In the
tumor microenvironment, TNC is produced by both transformed
tumor cells and stromal cells (Hanamura et al., 1997; Yoshida
et al., 1997; De Wever et al., 2004), and in vitro, the majority of
human melanoma cell lines secrete TNC (Herlyn et al., 1991).
Thus, an open question remains of whether the TNC expressed
by the melanoma cells can drive tumor cell invasion.
TNC is a hexameric protein composed of 180–320kDa
monomers, which are disulfide linked at the N termini. Each
subunit contains a globular N-terminal assembly domain, a
domain composed of 14.5 EGF-like (EGFL) repeats, a domain
composed of fibronectin type III–like repeats, and a fibrino-
gen-like sequence on the C terminus (Aukhil et al., 1993),
and each domain has a potentially distinct role
(Jones and Jones, 2000). TNC has been shown to modulate
many of the processes involved in cell migration and invasion
(reviewed in (Orend, 2005; Orend and Chiquet-Ehrismann,
2006)). The majority of cancer cell lines fail to attach on TNC-
coated surfaces (Huang et al., 2001), with some exceptions
where TNC is adhesive (Paron et al., 2011), whereas
endothelial cells attach and spread on TNC (Sriramarao
et al., 1993). In addition, soluble and substratum-adsorbed
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TNC have distinct effects on cell adhesion and proliferation
(Orend and Chiquet-Ehrismann, 2000). These seemingly
discrepant findings are in part traceable to the different
signaling propensities of the multiple domains of TNC being
impacted by the presence of other matrix components and the
potentially differential effects of signals in 2D vs 3D.
We have previously reported that distinct EGFL repeats of
TNC bind and signal through the EGF receptor in a novel
manner as ultra low-affinity/high-avidity ligands (Swindle
et al., 2001; Iyer et al., 2007). The ‘‘staccato’’ nature of the
individual EGFL repeat binding to the receptor results in an
anti-adhesive phenotype that must be balanced by the
adhesive matrix proteins or even the fibronectin-like repeats
of TNC. In the presence of adequate pro-adhesive moieties,
these EGFL repeats restrict signaling to the plasma membrane
and preferentially activate a motogenic signaling cascade
(Iyer et al., 2008). As little is known about TNC matrikine
role in melanoma, we tested the role of EGFL repeats in
melanoma motility and invasion. Herein we report that TNC
promotes melanoma cell invasion and that this activity can
be localized to the EGFL repeats.
RESULTS
Advanced melanoma cell lines express TNC and increase
migration in response to exogenous TNC
In melanoma, TNC is present at high concentrations in the
dermal matrix, having increased from negligible levels in
normal dermis (Tuominen and Kallioinen, 1994; Kaariai-
nen et al., 2006; Hood et al., 2010). We examined TNC
expression in human melanoma tissue microarray with the
antibody specific for the EGFL repeats of TNC (ab6393) and
observed that its expression increases with melanoma
progression (Figure 1a). To test whether melanoma
cell–derived TNC could be involved in dissemination, we
first examined expression levels in three melanoma cell
lines derived from different stages. The WM35 cells
derived from superficial spreading melanoma (radial/
vertical growth phase) expressed little if any TNC, similar
to human melanocytes (Hood et al., 2010), whereas
vertical growth phase WM983A and metastatic growth
phase cells derived from the same patient WM983B
expressed high levels of TNC (Figure 1b). This TNC was
incorporated into the cell-generated matrix in the extra-
cellular space and, of greater interest, the melanoma-
derived TNC was secreted asymmetrically at the front of
the invading melanoma cells, as observed by confocal
microscopy during the invasion of a Matrigel matrix (Figure
1c and d). In fact, we found that invasiveness of the three
melanoma cell lines directly correlated with the TNC
expression levels (R2¼ 0.83) (Figure 1e). These data
strongly suggest a role for TNC derived from the melanoma
itself as driving transmigration.
As motility is a predictive aspect of tumor invasion (Wells,
2000; Kassis et al., 2001) and consistent with reports of TNC
being motogenic (Chung et al., 1996; Swindle et al., 2001;
Nishio et al., 2005; Iyer et al., 2008; Paron et al., 2011),
melanoma cell lines expressing higher levels of TNC
migrated faster in live cell–tracking experiments and had
greater directional persistence, as measured by cell-track
straightness (Figure 1f, white bars). That the increase in cell
speed was due to the TNC incorporated into the substratum
was shown by adding TNC to the collagen-I coating on tissue
culture dishes; this further increased melanoma migration of
all three cell lines tested (Figure 1f, gray bars). Additionally,
there was a high correlation (R2¼0.99) between levels of
TNC being expressed by melanoma cells, but not
with exogenously added TNC, and cell-track straightness.
Cell-track straightness is a measure of the directionality
of cell movement and is a ratio between the displacement
of a cell and the track length for a set period of time,
implying a directional component to the endogenously
expressed TNC. These data suggest that both endogenously
produced and exogenously presented TNC contribute to
melanoma migration, but that the cells asymmetrically place
the endogenously produced TNC to promote directional
translocation.
TNCEGFL expression impairs migration of melanoma cells
in 2D
TNC is distinguished from most of the other Tenascin
family members by the inclusion and/or extent of the EGFL
repeat region. We have reported that at least some of
these EGFL repeats function as cryptic growth factors that
preferentially promote motility (Swindle et al., 2001; Iyer
et al., 2007). As multivalent concatamers of EGFL repeats
are difficult to synthesize and pose challenges to incorporat-
ing into matrices, we overexpressed the TNCEGFL repeats
transcript in the WM983A cell line (WM983A-TNCEGFL),
a cell line already expressing substantial amounts of
endogenous full-length TNC (TNCFULL), but responding to
additional exogenous TNC (Figure 1). A vertical growth-
phase melanoma cell line was chosen as a model system as
an intermediate phenotype of the cell lines tested regarding
motility in 2D and 3D assays, so that changes in
both directions could be observed. The TNCEGFL monomer
run in PAGE analyses at the predicted size of 69 kDa
and, as assessed under nonreducing conditions, assembled
in polymers with the endogenous TNCFULL (Figure 2a).
Staining with antibody that recognized the EGFL repeats
(MAB2138, R&D Systems, Minneapolis, MN) revealed that
TNCEGFL formed a punctuated extracellular network com-
pared with WM983A cells transfected with an empty vector
(WM983A-EV), which formed a prominent fibrillar TNC
mesh, supporting the role of TNC fibronectin-like repeats in
organization of the TNC extracellular network (Ramos et al.,
1998) (Figures 2b (lower panel) and 4b). Interestingly,
although WM983A-EV cells arranged themselves in a
distributed mesh, the WM983A-TNCEGFL cells aligned to
form cords (Figure 2b, upper panel).
Of interest, and unexpectedly, WM983A-TNCEGFL
cells migrated significantly slower in a 2D wound-healing
assay that measures directional collective 2D migration
(Figure 3a) and presented individually at a significantly
reduced average speed in live cell–tracking experiments
(3.9 nm s1) compared with WM983A-EV cells (4.5 nm s1)
(Figure 3b). Moreover, cell-track straightness was signifi-
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cantly reduced (Figure 3b, right panel) in WM983A-
TNCEGFL cells, suggesting that the loss in cell-movement
directionality in 2D is contributing to decrease in collective
cell migration. The phenotype was confirmed in the
WM35 cell line, which expresses little, if any, endogenous
TNC. Upon transient expression of either TNCFULL or
TNCEGFL, average cell speed and cell-track straightness
significantly decreased in 2D live cell–tracking experiments,
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with the TNCEGFL cells migrating the slowest (Supplemen-
tary Figure S1 online). This confirms the findings with the
overexpression of TNC constructs in the invasive melanoma
cells.
TNCEGFL expression impairs melanoma cell attachment
Migration speed in 2D results from a balance in adhesion and
contractility in a biphasic manner (DiMilla et al., 1991, 1993;
Lauffenburger and Horwitz, 1996). Decrease in adhesiveness
could alter the cell speed in an increasing or decreasing
manner, depending on the initial adhesiveness to substratum.
Examining this aspect, we found that TNCEGFL-expressing
cells were slower to adhere to and spread on substrata
(Figure 4a). In cell-spreading assays, TNCEGFL-expressing
cells started spreading with a 4-hour lag compared with
cells expressing an empty pcDNA3.1 vector (Figure 4a).
Furthermore, attachment of WM983A cells was inversely
correlated with the amount of TNCEGFL repeats being
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Figure 2. Expression of TNCEGFL in the WM983A cell line. (a) Immunoblotting of Tenascin-C (TNC) under nonreducing conditions with the antibody
recognizing EGF-like (EGFL) repeats (R&D Systems): whole-cell lysates and matrix are shown in the left panel and conditioned melanoma media are in the right.
Graphic depiction of the full-length TNC and TNCEGFL construct is provided. (b) Immunostaining of TNC: endogenous TNC forms a fibrillar mesh in the
extracellular matrix, while TNCEGFL is punctate (lower panel, original magnification  60; arrowheads point to the TNC fibers and punctae, respectively);
WM983A-TNCEGFL forms organized cords compared with unorganized WM983A-EV cell distribution (upper panel, original magnification  20). DAPI, 4’-6-
diamidino-2-phenylindole; EV, empty vector. Bar¼50 mm.
Figure 1. Expression of Tenascin-C (TNC) in human melanoma samples and cell lines and its influence on melanoma cell invasion and migration. (a) Tissue
microarray stained with the antibody recognizing EGF-like (EGFL) repeats of TNC (ab6393) (brown) and counterstained with hematoxylin. Bar¼ 50mm. Shown
are representative primary tumor samples. (b) Immunoblot and (c) immunostaining analyses show increased TNC protein expression and extracellular deposition
in vertical growth phase (VGP) and metastatic growth phase (MGP) melanoma cell lines compared with a cell line derived from superficially spreading
melanoma. Bar¼50 mm. Images are representative of at least three independent experiments. (d) During invasion in Matrigel, TNC is deposited at the fronts of
WM983A cells. The 3D model is of width 83 mm, height 85 mm, and depth 63 mm. (e) Melanoma cell lines expressing higher amounts of TNC invade to a greater
extent in Matrigel invasion assays (R2¼ 0.83). Shown is the mean±SD of three experiments. (f) Melanoma cell speed (left panel) increases on surfaces coated
with collagen I–Tenascin C mixture compared with collagen I alone, whereas cell-track straightness (displacement divided by total track length, right panel)
correlates with the levels of endogenous TNC expression (R2¼0.99) but does not change upon exogenous addition of TNC. Box and whisker plots summarize
the average from three independent experiments, N450 tracks per treatment in repeated experiments. *Po0.05 and **Po0.01 (box encompasses 25–75%, with
bars 10 (square)–90 ( )%, median is the triangle). DAPI, 4’-6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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expressed (Figure 4a and b). Although overexpression of the
TNCFULL did not impair cell attachment, expression of the
EGFL repeats suppressed attachment in a dose-dependent
manner. This phenotype was intrinsic, as the difference in
cell spreading and migration between WM983A-TNCEGFL
and WM983A-EV persisted on plastic culture dishes or
fibronectin-1–coated surfaces (Supplementary Figure S2A
online). The difference in adhesiveness was not likely due
to altered attachment proteins as the integrin profile of the
TNCEGFL-expressing cell line remained the same as the one
transfected with an empty vector, as determined by PCR
Array (SABiosciences, PAHS-013A) (Supplementary Table S1
online), nor was this an artifact of cell death, because
48 hours post plating there were equal cell numbers
(Supplementary Figure S2B online). The reduced adhesion
and spreading were due to an anti-adhesive phenotype of the
EGFL repeats, as quantified in inverted centrifugation assays.
Adherent WM983A-TNCEGFL cells detached to a greater
extent when subjected to centrifugal force than did
WM983A-EV cells (Figure 4c).
Expression of TNCEGFL activates Rho-associated kinase (ROCK)
signaling
The critical aspect of both cell migration and attachment/
spreading is the ratio of adhesion to transcellular contractility
(Lauffenburger and Horwitz, 1996). As integrin profiles were
similar and the phenotype persisted across different substrata,
we focused on contractility that creates tension within the
cell and determines the round cell shape (reviewed in Sanz-
Moreno and Marshall, 2010), mainly the ROCK and myosin
light chain 2 (MLC2). ROCK inhibitor Y27632 dramatically
improved adhesion and spreading of WM983A-TNCEGFL
cells when added at the time of plating (Figure 5a). The 2D
migration of WM983A-TNCEGFL cells was slightly but
statistically significantly increased when 5 mM Y27632 was
added at the time of introducing ‘‘the wound’’, compared
with the WM983A-EV (Figure 5b). This is in accordance with
findings that inhibition of ROCK in the absence of 3D
environment enhances cell movement (Sahai and Marshall,
2003) as it allows generation of protrusions and adhesion of
the leading edge.
Activated ROCK affects the state of MLC2 phosphorylation
by direct phosphorylation of MLC2 and by phosphorylation
and inhibition of MLC phosphatase (Amano et al., 2000).
Phosphorylation of MLC2 on Ser-19 is only partially
dependent on ROCK, whereas diphosphorylation on both
Thr-18 and Ser-19 and myosin phosphatase phosphorylation
(which is inhibitory to this contractility antagonist) on Thr-
853 are ROCK-dependent (Ren et al., 2004). It has been
shown that upon cell detachment Rho-ROCK signal trans-
duction is disrupted (Ren et al., 2004). Therefore, we
examined the phosphorylation status of these molecules in
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trypsinized (detached) and replated WM983A-EV and
WM983A-TNCEGFL cells during the time course of 8 hours
(Figure 5c). We observed that after detachment phosphoryla-
tion levels drop, and during the course of attachment
WM983A-EV cells gradually increase diphosphorylation of
MLC2 (ppMLC2), whereas TNCEGFL-expressing cells have
constant higher levels of ppMLC2. Monophosphorylation on
Ser-19, as expected, did not differ in WM983A-TNCEGFL
cells compared with WM983A-EV. Increased diphosphoryla-
tion of MLC2 may induce premature contraction and
decreased spreading, the phenotype that we observe in
TNCEGFL-expressing cells. Additionally, in TNCEGFL-ex-
pressing cells, phosphorylation of Thr-853 MYPT, a myosin-
binding subunit of myosin phosphatase that inhibits its
phosphatase activity, was increased compared with
WM983A-EV. Furthermore, transient expression of TNCFULL
or TNCEGFL in WM35 cells increased basal levels of ppMLC
(Supplementary Figure S1A online). As adhesion provides
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physical support for contraction and effective migration on
rigid substrates, our results imply that overly activated ROCK
and its effectors in TNCEGFL-expressing cells lead to
impaired cell attachment and movement in 2D.
TNCEGFL-expressing melanoma cells have increased invasion
potential
The foregoing presents a cell that is less attached to the
substrata, and likely exhibits greater shape plasticity, and thus
may preferentially move through a 3D matrix (Friedl et al.,
1998; Wolf et al., 2003). To address the question of the role
of TNCEGFL in 3D migration and invasion, we performed
Matrigel invasion experiments. WM983A-TNCEGFL cells had
rounded morphology in Matrigel, as observed by confocal
microscopy, and the phenotype could be reverted to the
elongated mesenchymal type in the presence of the ROCK
inhibitor (Figure 6a). In addition, WM983A-TNCEGFL cells
invaded to a greater extent than WM983A-EV cells (Figure
6b). Confocal imaging of individual invading cells in 3D
revealed that WM983A-TNCEGFL cells had rounded bleb-
bing morphology with high diphosphorylated MLC present in
the invading blebs, compared with WM983A-EV cells, which
had a mesenchymal morphology with filamentous protru-
sions (Figure 6c). Increased invasion potential was not due to
increased gelatinase activity as the activities of MMP2 and
MMP9 did not change (Supplementary Figure S2C online).
Our findings are in line with the notion that round melanoma
cells are able to squeeze through the gaps in ECM more
readily (Gaggioli and Sahai, 2007) as a result of strengthening
of the Rho/ROCK signaling pathway as one of the mechan-
isms leading to mesenchymal to amoeboid migration transi-
tion (reviewed in Friedl, 2004).
Finally, we tested the ability of WM983A-EV and
WM983A-TNCEGFL cells to invade into the collagen-rich
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dermis of an all-human skin organ culture, a model that
better captures melanoma invasion in the human skin.
Although WM983A-EV cells disrupted formation of stratified
epidermis, they did not invade into dermis in the 20-day
period. On the contrary, WM983A-TNCEGFL cells were able
to penetrate into the dermis compartment of skin organ
cultures (Figure 6d).
DISCUSSION
The most important step in progression from melanoma
in situ to advanced metastatic disease is acquiring invasive
ability. Advanced melanomas produce substantial amounts of
TNC that are thought to form fibrillar channels allowing
invasion (Kaariainen et al., 2006). Downregulating TNC in
melanoma cells leads to impaired lung colonization and
metastasis formation (Fukunaga-Kalabis et al., 2010); this was
also observed in TNC-deficient breast cancer cells in which
TNC maintains the metastatic niche (Oskarsson et al., 2011).
Therefore, increased levels of TNC secreted by melanoma
cells may not only promote tumor invasion but also
contribute to metastatic seeding. Despite the phenomenolo-
gical descriptions, the actual cellular mechanisms by which
TNC contributes to invasiveness of melanoma are not
defined. Herein, we show that one aspect driven by TNC is
the enhanced migration through matrices signaled by the
EGFL of this matrix molecule.
In this report, we show that advanced melanoma cell lines
themselves express large amounts of TNC that is incorporated
into the ECM, and further respond to exogenous TNC by
increasing migration speed. We observe that asymmetrical
placement of TNC at the cells’ front may promote directional
translocation during melanoma cell invasion. As TNC is
susceptible to proteolytic degradation by MMPs (Imai et al.,
1994; Siri et al., 1995) and EGFL repeats can be released or
‘‘uncovered’’ by this cleavage (Wallner et al., 2004), we
focused in particular on the possible impact of TNCEGFL
repeats on melanoma cell migration and invasion. We show
that overexpressing TNCEGFL impairs TNC extracellular
network organization and confers an intrinsic anti-adhesive
phenotype to melanoma cells, which is EGFL dose-depen-
dent. We find that TNCEGFL-expressing cells migrate slower
in 2D motility assays but move and have increased invasion
potential in 3D systems. Invading TNCEGFL-expressing cells
have rounded cell morphology, consistent with reports that
melanoma cells can shift to a less adhesive amoeboid mode
of cell movement (Sahai and Marshall, 2003). This dichotomy
of migration potential in 2D and 3D matrices has been noted
previously, with a shift in the adhesion contractility toward a
lesser overall value promoting speed through 3D matrices
while diminishing the locomotion on 2D surfaces (Zaman
et al., 2006). The mechanism of this shape plasticity in the
presence of TNCEGFL points to ROCK signaling, which
has been shown to allow melanoma switching between
mesenchymal and ameboidal types of cell movement (Sahai
and Marshall, 2003; Sanz-Moreno and Marshall, 2009). This
is consistent with signaling of the EGFL repeats via the EGFR.
However, we could not definitively demonstrate such a
pathway as EGFL repeats being at ultra-low affinity (Swindle
et al., 2001) and melanoma cells expressing low levels of
steady-state EGFR; further, the melanoma cells did not
survive in the face of EGFR inhibition (data not shown).
Nevertheless, proximity ligation assays (Soderberg et al.,
2006) implicate a close physical association (o40 nm) of
TNC and EGFR in these melanoma cells (Supplementary
Figure S3 online). Yet, in the absence of definitive evidence,
it is possible that the EGFL repeats signal via other surface
receptors.
It has been described that amoeboid-like melanoma cells
that have high ROCK activity are found at the invasive fronts
of melanomas, whereas mesenchymal elongated cells com-
prise the body of the tumors (Sanz-Moreno et al., 2011). We
find that TNCEGFL-expressing cells have increased ROCK
signaling, as observed by increased phosphorylation of its
targets: biphosphorylation of MLC2, which increases trans-
cellular contractility, and phosphorylation of MYPT, which
negates the inhibition of actin cytoskeleton contraction. This
is validated by the loss of the anti-adhesive phenotype and
rounded morphology in the presence of the ROCK inhibitor
Y27632 both on rigid 2D substrates and 3D Matrigel.
Furthermore, in the blebs of TNCEGFL-expressing cells
invading the 3D matrices, diphosphorylated MLC2 coloca-
lizes with the actin cytoskeleton; this is characteristic of
contractile amoeboid type of movement (reviewed in
Lammermann and Sixt, 2009). Finally, we show that
TNCEGFL-expressing cells are more efficient in invading into
a human skin organ culture, a setting that better resembles the
first steps of actual melanoma invasion in patients.
Supporting our signaling model, it has been shown that
recombinant TNC construct Ten70, which does not contain
EGFL repeats, suppresses Rho A activation while maintaining
the level of active Cdc42, thus preventing stress fiber
formation (Wenk et al., 2000). Cells seeded on Ten70 form
prominent filopodia, and this exact feature is lost in
TNCEGFL-expressing melanoma cells. By overexpressing
EGFL repeats, the balance of endogenous signaling of TNC
is shifted and activation of ROCK enables amoeboid
morphology. Our results are in concordance with the
observation that distinct modes of cell motility have different
requirements for ROCK activity (Sahai and Marshall, 2003),
as TNCEGFL-expressing cells perform better in 3D migration
assays and have impaired migration in 2D assays compared
with melanoma cells transfected with an empty vector. It is
interesting to speculate that TNC, highly expressed at the
invasion fronts of melanoma (Kaariainen et al., 2006)
and at the front of invading melanoma cells, promotes
activation of ROCK and amoeboid cell morphology observed
at the fronts of invasion in melanoma tumors (Sanz-Moreno
et al., 2011).
Taken together, our data demonstrate that overexpression
of TNCEGFL repeats alters both the adhesive and migratory
states of melanoma cells and the composition of the ECM,
making it more permissive for melanoma cell invasion. The
rounded morphology and enhanced blebbing of the amoe-
boid form of motility allows for cells to more easily penetrate
smaller-sized pores in matrices and thus are less dependent
on proteolytic ‘‘opening’’ of channels in a collagen-rich matrix,
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such as the dermis (Friedl, 2004). Our findings also reinforce
the notion that cells utilize different signaling cascades to
effect migration dependent on the 2D vs 3D matrix context.
MATERIALS AND METHODS
Cell culture
Melanoma cell line WM35, obtained from the Coriell Institute for
Medical Research (Camden, NJ), was maintained in MCDB153:L15
4:1 medium mixture with addition of 5% fetal bovine serum,
5mgml1 insulin, and 2mM CaCl2. WM983A and WM983B were
obtained from Wistar Institute (Philadelphia, PA) and cultured in
DMEM:L15 3:1 mixture with addition of 10% fetal bovine serum
(Herlyn et al., 1991). Human epidermal keratinocytes were obtained
from Invitrogen (Grand Island, NY) and cultured on collagen-coated
dishes in Epilife medium with growth supplements (Invitrogen).
Human neonatal fibroblasts were cultured in DMEM with 10% fetal
bovine serum. Primary cells were used in skin organ cultures under
the sixth passage.pt>
Generation of TNCEGFL and TNCFULL constructs and
TNCEGFL-expressing melanoma cell lines
TNCEGFL and TNCFULL constructs were generated by PCR
amplification from the X78565 TNCFULL in pNUT vector kindly
provided by Dr Harold Erickson (Duke University, Durham, NC).
Detailed information about the primer sequences and enzymes used
can be found in the Supplementary Methods and Materials online.
WM983A and WM35 cell lines were transfected with TNCEGFL or
TNCFULL using Lipofectamine (Invitrogen). WM35 cell line was
used 24 hours after transfection and WM983A clones stably
expressing TNCEGFL or TNCFULL were selected with G418.
Confocal imaging of Matrigel-invading cells
Matrigel invasion assay was performed in a BD BioCoat Matrigel
Invasion Chamber per manufacturer’s instructions (354480; BD
Biosciences, Bedford, MA). Forty-eight hours after cell seeding, gels
were fixed in 4% formaldehyde and 0.25% glutaraldehyde in PBS and
stained. Membranes with gels were excised and mounted on glass
slides with PBS. Detailed information about the staining procedure
and antibodies used can be found in the Supplementary Methods and
Materials online. Images were taken on Nikon Sweptfield Confocal
Microscope (Nikon Instruments, Melville, NY) (Trust Science Innova-
tion (TSI) inverted, Shoreview, MN) using  10 and  60 1.4
numerical aperture objectives. The 3D volume representations of Z-
stacks were made using Nikon Elements software.
Other methods
Further detailed information about cell-spreading quantification,
inverted centrifugation assays, 2D migration and tracking, and skin
organ cultures is provided in the Supplementary Methods and
Materials online.
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